United States Benign Prostatic Hyperplasia Treatment Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

1.      Report Overview

1.1.   Report Description

1.2.   Research Methods

1.3.   Research Approaches

2.      Executive Summary

3.      Market Overview

3.1.   Introduction

3.2.   Market Dynamics

3.2.1.Drivers

3.2.2.Restraints

3.2.3.Opportunities

3.2.4.Challenges

3.3.   PEST-Analysis

3.4.   Porter's Diamond Model for the United States Benign Prostatic Hyperplasia Treatment Market

3.5.   IGR-Growth Matrix Analysis

3.6.   Competitive Landscape in the United States Benign Prostatic Hyperplasia Treatment Market

4.      United States Benign Prostatic Hyperplasia Treatment Market by Therapeutic Class

4.1.   Alpha-blocker

4.2.   Phosphodiesterase-5 Inhibitor

4.3.   5-alpha Reductase Inhibitor

4.4.   Other Therapeutic Class

5.      United States Benign Prostatic Hyperplasia Treatment Market by Therapy

5.1.   Mono Drug Therapy

5.2.   Combination Drug Therapy

6.      United States Benign Prostatic Hyperplasia Treatment Market by End-user

6.1.   Hospitals

6.2.   Specialty Clinics

6.3.   Ambulatory Surgical Centers

6.4.   Other End Users

7.      Company Profiles

7.1.   Company 1

7.2.   Company 2

7.3.   Company 3

7.4.   Company 4

7.5.   Company 5